Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Avalo Therapeutics (AVTX) and Lifestance Health Group (LFST)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Solventum Corporation (SOLV – Research Report), Avalo Therapeutics (AVTX – Research Report) and Lifestance Health Group (LFST – Research Report) with bullish sentiments.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Solventum Corporation (SOLV)
BTIG analyst Ryan Zimmerman maintained a Buy rating on Solventum Corporation on January 2 and set a price target of $100.00. The company’s shares closed last Friday at $79.02.
According to TipRanks.com, Zimmerman is a 1-star analyst with an average return of
Currently, the analyst consensus on Solventum Corporation is a Moderate Buy with an average price target of $91.29, implying a 15.2% upside from current levels. In a report issued on December 19, TipRanks – OpenAI also reiterated a Buy rating on the stock with a $90.00 price target.
See the top stocks recommended by analysts >>
Avalo Therapeutics (AVTX)
BTIG analyst Julian Harrison maintained a Buy rating on Avalo Therapeutics on January 2 and set a price target of $40.00. The company’s shares closed last Friday at $17.02.
According to TipRanks.com, Harrison is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Avalo Therapeutics with a $37.33 average price target, a 105.2% upside from current levels. In a report issued on December 18, Mizuho Securities also initiated coverage with a Buy rating on the stock with a $39.00 price target.
Lifestance Health Group (LFST)
In a report issued on January 2, David Larsen from BTIG maintained a Buy rating on Lifestance Health Group, with a price target of $10.00. The company’s shares closed last Friday at $6.96.
According to TipRanks.com, Larsen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Lifestance Health Group with a $9.00 average price target.
